✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Centenial Surgical Suture Ltd.

CSURGSU

Market Cap
₹27 Cr.
P/E
0.00

Centenial Surgical Suture Ltd.

  • Centenial Surg. Sut.
  • Galaxy Medicare
  • GKB Ophthalmics

FAQs on Centenial Surgical Suture Ltd. Shareprice

Centenial Surg. Sut. has given lower returns compared to its competitors.
Centenial Surg. Sut. has grown at ~-19.57% over the last 2yrs while peers have grown at a median rate of -19.0%

Centenial Surg. Sut. is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Centenial Surg. Sut. is 0, while 3 year average PE is 27.85.
Also latest EV/EBITDA of Centenial Surg. Sut. is 7.37 while 3yr average is 6.9.

View FAQ's On Business

Growth Table

  • Centenial Surgical Suture Ltd.
  • Galaxy Medicare
  • GKB Ophthalmics

Balance Sheet

  • Centenial Surgical Suture Ltd.
  • Galaxy Medicare
  • GKB Ophthalmics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Centenial Surgical Suture Ltd.
  • Galaxy Medicare
  • GKB Ophthalmics

Cash Flow

  • Centenial Surgical Suture Ltd.
  • Galaxy Medicare
  • GKB Ophthalmics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Centenial Surgical Suture Ltd.
  • Galaxy Medicare
  • GKB Ophthalmics

Quarterly Results

  • Centenial Surgical Suture Ltd.
  • Galaxy Medicare
  • GKB Ophthalmics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Centenial Surgical Suture Ltd. Financials

Balance sheet of Centenial Surg. Sut. is moderately strong, But short term working capital might become an issue for this company.

The net debt of Centenial Surg. Sut. is decreasing.
Latest net debt of Centenial Surg. Sut. is ₹10.51 Crs as of Mar-26.
This is less than Mar-25 when it was ₹11.84 Crs.

No, profit is decreasing.
The profit of Centenial Surg. Sut. is -₹2.22 Crs for TTM, -₹1.46 Crs for Mar 2025 and ₹1.13 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Centenial Surg. Sut. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech